Webinar: The CAR Toolkit: Progress and Challenges in CAR T/NK Cell R&D and Manufacture
Webinar Summary
Chimeric antigen receptor (CAR) T cell immunotherapy has changed the face of cancer treatment and led to transformative clinical results in some patients. CAR-NK therapies are also gaining traction due to their potential to address some of the ongoing challenges with CAR T cells, such as safety and efficacy. With numerous clinical trials underway and multiple CAR T cell products now approved, solving the current obstacles when manufacturing CAR-T/NK cell products continues to be a pressing issue for the cellular immunotherapy field. In particular, the ability to evaluate the expression of a CAR following T cell or NK cell transduction is a critical step in the development and production of these cell therapy products. Watch this webinar, hosted by BioInsights, to hear about the current challenges, latest progress, and innovation facing CAR T and CAR NK development. In addition, a method for direct staining and detection of specific CARs by flow cytometry will be presented.
|